Back
MaxCyte Stock Predictions
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
17
MXCT
MaxCyte
Last Price:
3.42
Seasonality Move:
-8.13%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.MaxCyte Stock Forecast
Will MaxCyte Stock Go Up Next Year?
Data Unavailable
MaxCyte Stock Rating
Data Unavailable
MaxCyte Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
maxcyte.com
52-Week Data
52-Week High:
5.55
52-Week Low:
3.23
Prediction Charts
Market Cap:
360.75M
Price in USD:
3.42
Volume:
890.39K
Beta:
1.43
Technical Analysis
SMA50:
3.78
SMA100:
4.03
SMA200:
4.21
52-Wk Change:
-8.56%
Stock Predictions
-
Is MaxCyte stock public?
Yes, MaxCyte is a publicly traded company. -
What is the MaxCyte stock quote today?
The MaxCyte stock price is 3.42 USD today. -
How to buy MaxCyte stock online?
You can buy MaxCyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-29 | 3.65 | 3.57 | 3.65 | 3.50 |
| Oct-30 | 3.54 | 3.54 | 3.63 | 3.52 |
| Oct-31 | 3.52 | 3.58 | 3.67 | 3.52 |
| Nov-1 | 3.65 | 3.77 | 3.78 | 3.61 |
| Nov-4 | 3.73 | 3.77 | 3.82 | 3.66 |
| Nov-5 | 3.73 | 3.86 | 3.87 | 3.70 |
| Nov-6 | 4.00 | 3.88 | 4.13 | 3.80 |
| Nov-7 | 4.01 | 3.46 | 4.01 | 3.34 |
| Nov-8 | 3.45 | 3.39 | 3.64 | 3.37 |
| Nov-11 | 3.39 | 3.58 | 3.60 | 3.23 |
| Nov-12 | 3.51 | 3.54 | 3.64 | 3.43 |
| Nov-13 | 3.56 | 3.55 | 3.60 | 3.40 |
| Nov-14 | 3.55 | 3.44 | 3.61 | 3.41 |
| Nov-15 | 3.47 | 3.42 | 3.53 | 3.36 |
MaxCyte Earnings
Data Unavailable
MaxCyte Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.02 per share.
* MaxCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.